| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/27/2007 | CN1985828A Pulse controlled releasing Urapidil tablet and its preparing method |
| 06/27/2007 | CN1985821A Pharmaceutical use of smallflower thinleaf crazyweed total alkaloid and azahexacyclonone derivative |
| 06/27/2007 | CN1323079C Renin inhibitors |
| 06/27/2007 | CN1322870C Quality control method for speedwell flavone capsule |
| 06/27/2007 | CN1322864C Nicergoline drip pill and its preparing method |
| 06/26/2007 | US7235690 Anthranilamides and methods of their use |
| 06/26/2007 | US7235687 Derivatives of 4,4′-dithiobis-(3-aminobutane-1-sulfphonates) and compositions containing same |
| 06/26/2007 | US7235664 Potassium channel modulators; antiarrhythmia agents |
| 06/26/2007 | US7235658 Imidazol derivatives as Raf kinase inhibitors |
| 06/26/2007 | US7235635 IRAK-4: compositions and methods of use |
| 06/26/2007 | US7235634 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases |
| 06/26/2007 | US7235628 Analogues of GLP-1 |
| 06/26/2007 | US7235588 Administering tyrphostin janus associated kinase inhibitor |
| 06/26/2007 | US7235579 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators |
| 06/26/2007 | US7235570 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 06/26/2007 | US7235567 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 06/26/2007 | US7235566 Pyridinone derivatives for treatment of atherosclerosis |
| 06/26/2007 | US7235565 Quinoline and quinolinones 4-substituted with a 3-(hetero)cyclylcarbonyl-1-imidazolinyl or 3-(hetero)cyclylcarbonyl-1-imidazolinonyl group; treating diabetes, glomerulonephritis, endotoxic shock, psoriasis, and arthritis |
| 06/26/2007 | US7235561 Compound and a composition including such a compound |
| 06/26/2007 | US7235557 Benzo-1,5-naphthyridine and benzo-2,5-naphthyridine derivatives are used as poly(ADP-ribose) polymerase inhibitors for treating vascular stroke, cerebral ischemia, heart ischemia/reperfusion injury and gout |
| 06/26/2007 | US7235554 Water soluble; treating diseases in which peripheral benzodiazepine receptors are involved such as spinal amyotrophy, amyotrophic lateral sclerosis, cranial and medullar trauma, multiple sclerosis, and diabetic nephropathy |
| 06/26/2007 | US7235552 Cholenic acid amides and pharmaceutical compositions thereof |
| 06/26/2007 | US7235550 Polycyclic azaindole compounds |
| 06/26/2007 | US7235549 Benzamide, heteroarylamide and reverse amides |
| 06/26/2007 | US7235534 Oligonucleotide or polynucleotide for treating vascular healing after surgery, preventing atherosclerotic plaque, vein graft healing, cardiovascular disorders |
| 06/26/2007 | US7235532 Angiogenic agents and their uses |
| 06/26/2007 | US7235531 Tachykinin-like polypeptides and use thereof |
| 06/26/2007 | US7235380 CDR-grafted anti-tissue factor antibodies and methods of use thereof |
| 06/26/2007 | US7235372 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
| 06/26/2007 | US7235267 Brain cell or nerve cell-protecting agents comprising medicinal ginseng |
| 06/26/2007 | US7235264 Cerebral protection with a gas comprising xenon |
| 06/26/2007 | US7235259 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 06/26/2007 | CA2307792C Method for regulating size and growth of vascularized normal tissue |
| 06/26/2007 | CA2265464C Therapy for .alpha.-galactosidase a deficiency |
| 06/26/2007 | CA2235686C Indolin-2-one derivatives, process for their production and the pharmaceutical compositions containing them |
| 06/26/2007 | CA2215372C Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 06/26/2007 | CA2200516C Benzopyran derivative and method for treating heart disease using said benzopyran derivative |
| 06/26/2007 | CA2185037C Iridaceae extract and compositions containing the same |
| 06/22/2007 | CA2550417A1 Method for maintaining cerebral hemispheric oxygen saturation during surgery |
| 06/21/2007 | WO2007070201A1 Aspartic protease inhibitors |
| 06/21/2007 | WO2007069986A1 New oxabispidine compounds for the treatment of cardiac arrhythmias |
| 06/21/2007 | WO2007069827A1 Pharmaceutical composition with extended release layer and fast release layer for treatment of hyperlipidemia and arteriosclerosis |
| 06/21/2007 | WO2007069758A1 Composition having ppar ligand activity |
| 06/21/2007 | WO2007069669A1 Pharmaceutical composition for enhancing adiponectin production |
| 06/21/2007 | WO2007069635A1 Vla-4 inhibitory drug |
| 06/21/2007 | WO2007069358A1 Novel preparation of gastric retention type |
| 06/21/2007 | WO2007068948A2 Pharmaceutical sustained release compositions comprising in particular thyroid hormones |
| 06/21/2007 | WO2007068829A1 Orodispersible pharmaceutical composition for oral, oromucosal or sublingual administration of agomelatine |
| 06/21/2007 | WO2007068739A1 4-amino-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, neurological and cardiovascular disorders |
| 06/21/2007 | WO2007068495A1 Salts of clopidogrel with polynions and their use for manufacturing pharmaceutical formulations |
| 06/21/2007 | WO2007068434A2 Medicament based on a monoester of steroids with long chain fatty acids |
| 06/21/2007 | WO2007068212A1 Intravenous emulsion of butylbenzene phthalein and its application |
| 06/21/2007 | WO2007068171A1 CRYSTALLINE FORM I OF 3,4',5-TRIHYDROXY-STIBENE-3-β-D-GLUCOSIDE |
| 06/21/2007 | WO2007068070A2 Composition containing an inhibitor of phosphodiesterase iii and a therapeutic alcohol for the treatment of atherosclerosis diseases |
| 06/21/2007 | WO2007017893B1 Preparation of novel crystalline form of perindopril erbumine monohydrate |
| 06/21/2007 | WO2007014392A3 Benzoquinones of enhanced bioavailability |
| 06/21/2007 | WO2007011757A8 Use of inhibitors of the ubiquitin proteasome pathway for increasing contractility of the heart |
| 06/21/2007 | WO2007005763A3 Combination of a renin inhibitor and an insulin secretion enhancer or an insulin sensitizer |
| 06/21/2007 | WO2006101782A3 A cysteine-containing peptide tag for site-specific conjugation of proteins |
| 06/21/2007 | WO2002100330A9 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES |
| 06/21/2007 | US20070142875 Stimulation of the sphenopalatine ganglion for treating depression |
| 06/21/2007 | US20070142718 Noninvasive measurement of chemical substances |
| 06/21/2007 | US20070142476 Biphenyl-Derivatives as p38 Kinase Inhibitors |
| 06/21/2007 | US20070142470 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate |
| 06/21/2007 | US20070142465 Macrophage activation inhibitor |
| 06/21/2007 | US20070142451 Crystalline form of carvedilol hydrobromide, which is the hydrobromide salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol, and/or other carvedilol solvates thereof for treatment of hypertension, congestive heart failure, and angina |
| 06/21/2007 | US20070142449 Angiogenesis inhibitors |
| 06/21/2007 | US20070142442 Stabilized pharmaceutical compositions containing a calcium channel blocker |
| 06/21/2007 | US20070142430 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereof |
| 06/21/2007 | US20070142420 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 06/21/2007 | US20070142408 Compositions and methods for inhibiting TGF-Beta |
| 06/21/2007 | US20070142386 New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1 |
| 06/21/2007 | US20070142375 Pyrrolidine derivatives as factor xa inhibitors |
| 06/21/2007 | US20070142374 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 06/21/2007 | US20070142352 Pteridinone Derivatives as Modulators of Chemokine Receptor Activity |
| 06/21/2007 | US20070142350 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates |
| 06/21/2007 | US20070142342 Pharmaceutical compounds |
| 06/21/2007 | US20070142341 Use of steroid derivatives for the treatment of angiotensin ll related disease e.g. cardiovascular and proliferative disorders |
| 06/21/2007 | US20070142340 Steroids as agonists for FXR |
| 06/21/2007 | US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ |
| 06/21/2007 | US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
| 06/21/2007 | US20070142314 Administering a nucleotide decoy of an ets gene or a chimera decoy of NF-Kappa B with a hydrophillic polymer carrier sheet; aneurysm, Marfan's syndrome, aortic detachment, and plaque rupture |
| 06/21/2007 | US20070142294 Identification and cloning of novel human gene, RET16, involved in the intracellular signaling cascade |
| 06/21/2007 | US20070142283 Angiogenically effective unit dose of FGF-2 and method of use |
| 06/21/2007 | US20070142280 Factor VII or VIIa-like molecules |
| 06/21/2007 | US20070142274 Fish protein hydrolyzate |
| 06/21/2007 | US20070141669 Pregnancy-associated plasma protein-A2 (PAPP-A2) |
| 06/21/2007 | US20070141634 Assay |
| 06/21/2007 | US20070141184 Composition for oral administration containing capsaicinoids |
| 06/21/2007 | US20070141173 Medicament comprising noble metal fine particles |
| 06/21/2007 | US20070141109 Local Deliver of 17-Beta Estradiol for Preventing Vascular Intimal Hyperplasia and for Improving Vascular Endothelium Function after Vascular Injury |
| 06/21/2007 | US20070141083 Use of a single-cell protein material |
| 06/21/2007 | US20070140987 Promoting whole body health |
| 06/21/2007 | US20070140984 Functional powdery product |
| 06/21/2007 | DE60125036T2 Hydroxyformamidin-derivate und diese enthaltende medikamente Hydroxyformamidin derivatives and containing the same drug |
| 06/21/2007 | DE60121550T2 Pyrimidin-4-onderivat als LDL-PLA2 Inhibitor Pyrimidin-4-one derivative as LDL-PLA2 inhibitor |
| 06/21/2007 | DE102005060393A1 Pharmaceutical pellet, useful for the production of tablet, comprises a spherical active agent, preferably metroprololsuccinate, comprising core with smooth surface and a coat on the core, where the active agent release is pH-independent |
| 06/21/2007 | CA2634168A1 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 06/21/2007 | CA2634006A1 Pharmaceutical sustained release compositions comprising liothyronine or the sodium salt of liothyronine |
| 06/21/2007 | CA2631658A1 Salts of clopidogrel with polyanions and their use for manufacturing pharmaceutical formulations |